Using RevCore Catheter to Treat Stent Blockages
Official title: RevCore for In Stent Thrombosis (REVIT)
Run by Inari Medical · NCT06394739 · Data updated 2026-11-12
This study is testing whether the RevCore Catheter can help people with blood clots in their stents in the legs feel better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Inari Medical Industry-sponsored |
| Locations | 17 sites (New Haven, Connecticut and 16 other locations) |
| Status | Recruiting |
| Started | September 9, 2024 |
| Main results expected | April 2027 |
| Study ends | April 2028 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT06394739 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with thrombosed stents located in specific deep vein segments of the lower extremities.
✕Probably not a fit
Patients with severely damaged stents, bilateral in-stent thrombosis, or certain medical contraindications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research aims to gather data on the effectiveness of the RevCore Thrombectomy Catheter in treating in-stent thrombosis, which occurs when blood clots form within stents. The study will observe patients who have experienced stent blockages in specific deep vein segments of the lower extremities. Participants will be monitored to assess the catheter's performance and outcomes related to the treatment of these blockages. The study is observational, meaning it will collect data without altering the standard treatment protocols.
Why it matters
Potential benefit: If successful, this study could improve treatment options for patients suffering from stent blockages, potentially leading to better outcomes and reduced complications.
How similar studies have gone: While this approach is being evaluated in this specific context, similar thrombectomy techniques have shown promise in treating vascular blockages in other studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Patients with stent age \> 6 weeks 3. Location of thrombosed stents in proximal lower extremity deep vein segments including at least common femoral, external iliac, or common iliac vein 4. RevCore Thrombectomy Catheter must enter vasculature 5. Willing and able to provide informed consent Exclusion Criteria: 1. Exposed stents with broken struts, significantly deformed struts, struts protruding into the vessel 2. Stents not wall apposed 3. Stents compressed to \<10mm 4. Bilateral in-stent thrombosis 5. Congenital anatomic anomalies of the iliac veins 6. Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast agents, except for mild to moderate contrast allergies for which pretreatment can be used 7. Any contraindication to anticoagulants or antiplatelets that, in the opinion of the Investigator, cannot be medically managed throughout the study period 8. Chronic non-ambulatory status 9. Known hypercoagulable states (e.g. antiphospholipid syndrome) that, in the opinion of the Investigator, cannot be medically managed throughout the study period 10. Inability to secure venous access 11. Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject 12. Current participation in another investigational drug or device treatment study
Where it's running
-
Yale University
New Haven, Connecticut, United States Recruiting -
Medstar Health Research Institute
Washington D.C., District of Columbia, United States Recruiting -
St. Luke's Hospital Boise
Boise, Idaho, United States Recruiting -
University of Maryland
Baltimore, Maryland, United States Recruiting -
New York University- Langone
New York, New York, United States Recruiting -
Mission Health
Asheville, North Carolina, United States Recruiting
Show 11 more locations
-
UH Cleveland Medical Center
Cleveland, Ohio, United States Recruiting -
Ohio State University
Columbus, Ohio, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
Allegheny Health Network Research Institute
Pittsburgh, Pennsylvania, United States Recruiting -
Spartanburg Medical Center
Spartanburg, South Carolina, United States Recruiting -
El Paso Cardiology Associates
El Paso, Texas, United States Recruiting -
Baylor Scott & White Research Institute
Plano, Texas, United States Recruiting -
Sentara
Norfolk, Virginia, United States Recruiting -
University of Washington
Seattle, Washington, United States Recruiting -
West Virginia University- Ruby Memorial
Morgantown, West Virginia, United States Recruiting -
Thomas Jefferson University
Philadelphia, Pennsylvania, United States Withdrawn
Study contacts
- Study coordinator: Jenifer Foss
- Email: jenifer.foss@stryker.com
- Phone: (978)-587-6598
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Artix Thrombectomy System for acute lower limb arterial occlusion
This study tests the Artix Thrombectomy System to remove clots and restore blood flow in adults with acute lower limb arterial occlusions.
-
Registry for patients treated with Inari Medical devices for pulmonary embolism
This study collects information from patients treated for pulmonary embolism using Inari Medical devices to see how well they work and how safe they are in real life.
-
Comparing FlowTriever System to Standard Care for High-Risk Pulmonary Embolism
This study tests if the FlowTriever System can help people with high-risk pulmonary embolism feel better compared to standard treatment.
-
Comparison of ClotTriever System and Anticoagulation for Deep Vein Thrombosis
This study is testing if the ClotTriever System can help people with painful deep vein blood clots feel better compared to the usual blood-thinning medications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.